Reactivatability of soman-inhibited end plate cholinesterase and neuromuscular transmission.
D000110:Acetylcholinesterase / Q000378:metabolism*; D000818:Animals; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D003964:Diaphragm / Q000201:enzymology; D004285:Dogs; D005260:Female; D005458:Fluoride Poisoning / Q000201:enzymology*; D006651:Histocytochemistry; D066298:In Vitro Techniques; D008297:Male; D009469:Neuromuscular Junction / Q000187:drug effects / Q000201:enzymology*; D009584:Nitrogen; D062025:Organophosphate Poisoning; D063065:Organophosphonates / Q000494:pharmacology; D011220:Pralidoxime Compounds / Q000494:pharmacology*; D051381:Rats; D009435:Synaptic Transmission / Q000187:drug effects*; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D063065:Organophosphonates; D011220:Pralidoxime Compounds; D000110:Acetylcholinesterase; D009584:Nitrogen